140 related articles for article (PubMed ID: 7187189)
1. [Acquired leukomelanoderma caused by topical depigmenting agents].
Grojean MF; Thivolet J; Perrot H
Ann Dermatol Venereol; 1982; 109(8):641-7. PubMed ID: 7187189
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid synergistically enhances the melanocytotoxic and depigmenting effects of monobenzylether of hydroquinone in black guinea pig skin.
Kasraee B; Fallahi MR; Ardekani GS; Ebrahimi S; Doroudchi G; Omrani GR; Handjani F; Amini M; Tanideh N; Haddadi M; Nikbakhsh M; Jahanbani S; Tran C; Sorg O; Saurat JH
Exp Dermatol; 2006 Jul; 15(7):509-14. PubMed ID: 16761959
[TBL] [Abstract][Full Text] [Related]
3. Depigmentation therapies for normal skin in vitiligo universalis.
AlGhamdi KM; Kumar A
J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):749-57. PubMed ID: 21054565
[TBL] [Abstract][Full Text] [Related]
4. Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation.
Hariharan V; Klarquist J; Reust MJ; Koshoffer A; McKee MD; Boissy RE; Le Poole IC
J Invest Dermatol; 2010 Jan; 130(1):211-20. PubMed ID: 19657355
[TBL] [Abstract][Full Text] [Related]
5. [Accidental leukomelanoderma induced by topical depigmenting agents].
Frenk E
Ann Dermatol Venereol; 1983; 110(4):381-2. PubMed ID: 6625461
[No Abstract] [Full Text] [Related]
6. Depigmentation caused by phenolic detergent germicides.
Kahn G
Arch Dermatol; 1970 Aug; 102(2):177-87. PubMed ID: 5430313
[No Abstract] [Full Text] [Related]
7. Effects of Monobenzyl ether of hydroquinone on 3T3 mouse fibroblast viability and ultrastructure.
Erdoğan A; Mutlu HS; Doğan S; Kotil T
Ultrastruct Pathol; 2021 Nov; 45(6):384-390. PubMed ID: 34875974
[TBL] [Abstract][Full Text] [Related]
8. [Experimental depigmentation of black guinea pig skin. Comparative study of depigmentary action of monoethyl ether of hydroquinone and N-(mercaptoethyl-)-dimethylamine].
Frenk E
Ann Dermatol Syphiligr (Paris); 1970; 97(3):287-96. PubMed ID: 5455227
[No Abstract] [Full Text] [Related]
9. [Exogenous ochronosis, a little-known side effect of hydroquinone-containing ointments].
Menke HE; Dekker SK; Noordhoek Hegt V; Pavel S; Westerhof W
Ned Tijdschr Geneeskd; 1992 Jan; 136(4):187-90. PubMed ID: 1736131
[TBL] [Abstract][Full Text] [Related]
10. Q-Switched Alexandrite Laser and Topical 20% Monobenzyl Ester of Hydroquinone Removal of Tacrolimus-Induced Repigmentation (After Complete Depigmentation With 20% Monobenzyl Ether of Hydroquinone).
McGuinn KP; Saedi N; Green JB; Dover JS
Dermatol Surg; 2019 May; 45(5):756-757. PubMed ID: 30893165
[No Abstract] [Full Text] [Related]
11. Targeting melanocyte and melanoma stem cells by 8-hydroxy-2-dipropylaminotetralin.
Bonchak JG; Eby JM; Willenborg KA; Chrobak D; Henning SW; Krzywiec A; Johnson SL; Le Poole IC
Arch Biochem Biophys; 2014 Dec; 563():71-8. PubMed ID: 25132642
[TBL] [Abstract][Full Text] [Related]
12. [Experimental skin depigmentation. II. Epidermal reaction in external administration of depigmenting substances].
Wohlrab W; Zaumseil RP
Dermatol Monatsschr; 1976 Dec; 162(12):980-5. PubMed ID: 1021476
[No Abstract] [Full Text] [Related]
13. [Depigmentation effect of hydroquinone monomethyl ether].
Durmischev AL; Davidoff MS
Dermatol Monatsschr; 1976 Apr; 162(4):306-11. PubMed ID: 955213
[No Abstract] [Full Text] [Related]
14. [Evaluation of an antioxidant and mitochondria-stimulating cream formula on the skin of patients with stable common vitiligo].
Rojas-Urdaneta JE; Poleo-Romero AG
Invest Clin; 2007 Mar; 48(1):21-31. PubMed ID: 17432541
[TBL] [Abstract][Full Text] [Related]
15. FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo.
Lan CC; Chen GS; Chiou MH; Wu CS; Chang CH; Yu HS
Br J Dermatol; 2005 Sep; 153(3):498-505. PubMed ID: 16120133
[TBL] [Abstract][Full Text] [Related]
16. [Confetti-like dyschromia caused by a bleaching cream containing hydroquinone in racially pigmented patients].
Haas N
Med Klin (Munich); 1988 May; 83(11):385-6, 390. PubMed ID: 3405155
[No Abstract] [Full Text] [Related]
17. Monobenzylether of hydroquinone. A retrospective study of treatment of 18 vitiligo patients and a review of the literature.
Mosher DB; Parrish JA; Fitzpatrick TB
Br J Dermatol; 1977 Dec; 97(6):669-79. PubMed ID: 603749
[TBL] [Abstract][Full Text] [Related]
18. Depigmentation Therapies for Vitiligo.
Grimes PE; Nashawati R
Dermatol Clin; 2017 Apr; 35(2):219-227. PubMed ID: 28317530
[TBL] [Abstract][Full Text] [Related]
19. [Depigmentation for cosmetic purposes: prevalence and side-effects in a female population in Senegal].
Raynaud E; Cellier C; Perret JL
Ann Dermatol Venereol; 2001; 128(6-7):720-4. PubMed ID: 11460033
[TBL] [Abstract][Full Text] [Related]
20. Monobenzone, Superfade, vitiligo and confetti-like depigmentation.
Catona A; Lanzer D
Med J Aust; 1987 Mar; 146(6):320-1. PubMed ID: 3821640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
